{"id":38181,"date":"2025-09-10T07:00:56","date_gmt":"2025-09-10T07:00:56","guid":{"rendered":"https:\/\/updates-www.mccdn.io\/vitals\/?p=38181"},"modified":"2025-11-12T23:19:03","modified_gmt":"2025-11-12T23:19:03","slug":"managing-metastatic-prostate-cancer-with-innovative-care","status":"publish","type":"post","link":"https:\/\/updates-www.mccdn.io\/vitals\/managing-metastatic-prostate-cancer-with-innovative-care\/","title":{"rendered":"Managing metastatic prostate cancer with innovative care","gt_translate_keys":[{"key":"rendered","format":"text"}]},"content":{"rendered":"<p>Vashon Island resident Timothy Taylor, 68, enjoys fishing and gardening. Four years ago, however, a sudden health issue forced him to temporarily set those activities aside.<\/p>\n<p>\u201cIt all started when I couldn\u2019t pee,\u201d he recalls. \u201cI went to the ER, they put in a catheter and referred me to a urologist.\u201d<\/p>\n<p>Following his visit to the emergency department, Taylor went to MultiCare Urology Northwest, where his prostate-specific antigen (PSA) level was checked.<\/p>\n<p>Taylor\u2019s PSA was 1,614 \u2014 more than 20 is considered high risk for prostate cancer. He proceeded to have a biopsy and PET scan. His biopsy came back positive, and his PET scan showed the cancer had metastasized to his bones.<\/p>\n<p>Faced with the news, Taylor\u2019s thoughts turned to his family\u2019s history with cancer.<\/p>\n<p>\u201cI thought, my father had lung cancer, my brother had throat cancer, one of my sisters had lung cancer, the other sister had breast cancer \u2014 I have it now, what do we do?\u201d he says.<\/p>\n<p>What he did was begin a comprehensive and aggressive treatment plan after meeting with <a href=\"https:\/\/updates-www.mccdn.io\/provider\/jennifer-slim\/\">Jennifer Slim, DO<\/a>, a medical oncologist with MultiCare Cancer Institute. Over the next four years, he underwent eight rounds of chemotherapy, supplemented with receiving androgen deprivation therapy (an antihormonal treatment) every three months.<\/p>\n<p>\u201cDr. Slim is wonderful,\u201d Taylor says. \u201cIn fact, all the doctors and nurses I\u2019ve encountered at MultiCare have been very informative and helpful.\u201d<\/p>\n<p>After several years, the chemotherapy started to become less effective and the cancer began to progress again, which is a common challenge with prostate cancer.<\/p>\n<p>\u201cProstate cancer typically responds very well to treatment, but then eventually the cancer outsmarts the treatments we&#8217;re using, and then you have to switch course,\u201d says Taylor\u2019s radiation oncologist <a href=\"https:\/\/updates-www.mccdn.io\/provider\/susan-guo\/\">Susan Guo, MD<\/a>.<\/p>\n<h2><strong>New treatment effectively targets cancer cells<\/strong><\/h2>\n<p>Taylor\u2019s care team turned to a newer treatment specifically used to treat\u00a0metastatic prostate cancer called Pluvicto.<\/p>\n<p>Pluvicto, a <a href=\"https:\/\/updates-www.mccdn.io\/services\/cancer-care\/treatment-options\/radiation-therapy\/radioligand-therapy\/\">radioligand therapy<\/a>, has been shown to improve survival rates and delay cancer progression. The treatment is delivered through IV injections once every six weeks for six cycles, directly targeting cancer cells. This minimizes damage to surrounding healthy tissue, which reduces common side effects seen with traditional chemotherapy or external radiation.<\/p>\n<p>The impact of Pluvicto on Taylor\u2019s cancer was immediate and significant.<\/p>\n<p>\u201cMr. Taylor has had two treatments so far, and already has had very promising results,\u201d Dr. Guo explains. \u201cBefore his first treatment, his PSA was 50. After the first treatment, it went down to 11. And after the second, it went to 2.\u201d<\/p>\n<p>Dr. Slim, who continues to oversee Taylor\u2019s care, agrees.<\/p>\n<p>\u201cThe Pluvicto treatment doubled his response rate compared to previous standards of care,\u201d she adds. \u201cThat\u2019s pretty powerful.\u201d<\/p>\n<p>Once Taylor completes the full Pluvicto regimen, he\u2019ll continue follow-up visits every few months with Dr. Guo and Dr. Slim. They\u2019ll monitor his PSA levels and watch for any sign of progression on imaging. He will also remain on androgen deprivation therapy as part of his ongoing care plan.<\/p>\n<p>\u201cWhen prostate cancer is metastatic, it\u2019s treated as a chronic disease,\u201d Dr. Guo explains.<\/p>\n<p>\u201cMr. Taylor has had such a good response, there is some suggestion his cancer won\u2019t progress for a while, and he can enjoy good quality of life without too many side effects.\u201d<\/p>\n<p>For Taylor, who has been battling this disease for years, the new treatment represents more than just medical progress \u2014 it gives him a chance to better enjoy the things he likes to do.<\/p>\n<p>\u201cFor a patient like Mr. Taylor, who has been fighting cancer with grace for a long time, getting a new opportunity that gives him options other than chemo and a break from those side effects is a wonderful thing,\u201d Dr. Slim says. \u201cHis strength and stamina during treatment have been inspiring to me as his provider.\u201d<\/p>\n","protected":false,"gt_translate_keys":[{"key":"rendered","format":"html"}]},"excerpt":{"rendered":"<p>Vashon Island resident Timothy Taylor, 68, enjoys fishing and gardening. Four years ago, however, a sudden health issue forced him to temporarily set those activities aside. \u201cIt all started when I couldn\u2019t pee,\u201d he recalls. \u201cI went to the ER, they put in a catheter and referred me to a urologist.\u201d Following his visit to [&hellip;]<\/p>\n","protected":false,"gt_translate_keys":[{"key":"rendered","format":"html"}]},"author":451,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[43,79],"tags":[167],"class_list":["post-38181","post","type-post","status-publish","format-standard","hentry","category-cancer","category-profiles-stories","tag-prostate-cancer"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.6 (Yoast SEO v27.6) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Managing metastatic prostate cancer with innovative care - MultiCare Vitals<\/title>\n<meta name=\"description\" content=\"When chemotherapy became less effective against Timothy Taylor\u2019s prostate cancer, his care team turned to a newer treatment called Pluvicto.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/updates-www.mccdn.io\/vitals\/managing-metastatic-prostate-cancer-with-innovative-care\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Managing metastatic prostate cancer with innovative care - MultiCare Vitals\" \/>\n<meta property=\"og:description\" content=\"When chemotherapy became less effective against Timothy Taylor\u2019s prostate cancer, his care team turned to a newer treatment called Pluvicto.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/updates-www.mccdn.io\/vitals\/managing-metastatic-prostate-cancer-with-innovative-care\/\" \/>\n<meta property=\"og:site_name\" content=\"MultiCare Vitals\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/multicarehealthsystem\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-10T07:00:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-11-12T23:19:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/updates-www.mccdn.io\/vitals\/wp-content\/uploads\/sites\/15\/2025\/09\/Tim-bkg.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1108\" \/>\n\t<meta property=\"og:image:height\" content=\"623\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Helen Vik\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/updates-www.mccdn.io\\\/vitals\\\/managing-metastatic-prostate-cancer-with-innovative-care\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/updates-www.mccdn.io\\\/vitals\\\/managing-metastatic-prostate-cancer-with-innovative-care\\\/\"},\"author\":{\"name\":\"Helen Vik\",\"@id\":\"https:\\\/\\\/updates-www.mccdn.io\\\/vitals\\\/#\\\/schema\\\/person\\\/7b42102cc747c1354973d979a644ceb6\"},\"headline\":\"Managing metastatic prostate cancer with innovative care\",\"datePublished\":\"2025-09-10T07:00:56+00:00\",\"dateModified\":\"2025-11-12T23:19:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/updates-www.mccdn.io\\\/vitals\\\/managing-metastatic-prostate-cancer-with-innovative-care\\\/\"},\"wordCount\":643,\"publisher\":{\"@id\":\"https:\\\/\\\/updates-www.mccdn.io\\\/vitals\\\/#organization\"},\"keywords\":[\"Prostate Cancer\"],\"articleSection\":[\"Cancer\",\"Profiles &amp; Patient Stories\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/updates-www.mccdn.io\\\/vitals\\\/managing-metastatic-prostate-cancer-with-innovative-care\\\/\",\"url\":\"https:\\\/\\\/updates-www.mccdn.io\\\/vitals\\\/managing-metastatic-prostate-cancer-with-innovative-care\\\/\",\"name\":\"Managing metastatic prostate cancer with innovative care - MultiCare Vitals\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/updates-www.mccdn.io\\\/vitals\\\/#website\"},\"datePublished\":\"2025-09-10T07:00:56+00:00\",\"dateModified\":\"2025-11-12T23:19:03+00:00\",\"description\":\"When chemotherapy became less effective against Timothy Taylor\u2019s prostate cancer, his care team turned to a newer treatment called Pluvicto.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/updates-www.mccdn.io\\\/vitals\\\/managing-metastatic-prostate-cancer-with-innovative-care\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/updates-www.mccdn.io\\\/vitals\\\/managing-metastatic-prostate-cancer-with-innovative-care\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/updates-www.mccdn.io\\\/vitals\\\/managing-metastatic-prostate-cancer-with-innovative-care\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/updates-www.mccdn.io\\\/vitals\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Managing metastatic prostate cancer with innovative care\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/updates-www.mccdn.io\\\/vitals\\\/#website\",\"url\":\"https:\\\/\\\/updates-www.mccdn.io\\\/vitals\\\/\",\"name\":\"MultiCare Vitals\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/updates-www.mccdn.io\\\/vitals\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/updates-www.mccdn.io\\\/vitals\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/updates-www.mccdn.io\\\/vitals\\\/#organization\",\"name\":\"MultiCare\",\"url\":\"https:\\\/\\\/updates-www.mccdn.io\\\/vitals\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/updates-www.mccdn.io\\\/vitals\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/updates-www.mccdn.io\\\/vitals\\\/wp-content\\\/uploads\\\/sites\\\/15\\\/2021\\\/05\\\/MultiCare-Color.png\",\"contentUrl\":\"https:\\\/\\\/updates-www.mccdn.io\\\/vitals\\\/wp-content\\\/uploads\\\/sites\\\/15\\\/2021\\\/05\\\/MultiCare-Color.png\",\"width\":1500,\"height\":409,\"caption\":\"MultiCare\"},\"image\":{\"@id\":\"https:\\\/\\\/updates-www.mccdn.io\\\/vitals\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/multicarehealthsystem\",\"https:\\\/\\\/www.instagram.com\\\/multicarehealth\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/multicare-health-system\\\/mycompany\\\/\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/multicarehealth\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/updates-www.mccdn.io\\\/vitals\\\/#\\\/schema\\\/person\\\/7b42102cc747c1354973d979a644ceb6\",\"name\":\"Helen Vik\",\"url\":\"https:\\\/\\\/updates-www.mccdn.io\\\/vitals\\\/author\\\/helenvik\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Managing metastatic prostate cancer with innovative care - MultiCare Vitals","description":"When chemotherapy became less effective against Timothy Taylor\u2019s prostate cancer, his care team turned to a newer treatment called Pluvicto.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/updates-www.mccdn.io\/vitals\/managing-metastatic-prostate-cancer-with-innovative-care\/","og_locale":"en_US","og_type":"article","og_title":"Managing metastatic prostate cancer with innovative care - MultiCare Vitals","og_description":"When chemotherapy became less effective against Timothy Taylor\u2019s prostate cancer, his care team turned to a newer treatment called Pluvicto.","og_url":"https:\/\/updates-www.mccdn.io\/vitals\/managing-metastatic-prostate-cancer-with-innovative-care\/","og_site_name":"MultiCare Vitals","article_publisher":"https:\/\/www.facebook.com\/multicarehealthsystem","article_published_time":"2025-09-10T07:00:56+00:00","article_modified_time":"2025-11-12T23:19:03+00:00","og_image":[{"width":1108,"height":623,"url":"https:\/\/updates-www.mccdn.io\/vitals\/wp-content\/uploads\/sites\/15\/2025\/09\/Tim-bkg.png","type":"image\/png"}],"author":"Helen Vik","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/updates-www.mccdn.io\/vitals\/managing-metastatic-prostate-cancer-with-innovative-care\/#article","isPartOf":{"@id":"https:\/\/updates-www.mccdn.io\/vitals\/managing-metastatic-prostate-cancer-with-innovative-care\/"},"author":{"name":"Helen Vik","@id":"https:\/\/updates-www.mccdn.io\/vitals\/#\/schema\/person\/7b42102cc747c1354973d979a644ceb6"},"headline":"Managing metastatic prostate cancer with innovative care","datePublished":"2025-09-10T07:00:56+00:00","dateModified":"2025-11-12T23:19:03+00:00","mainEntityOfPage":{"@id":"https:\/\/updates-www.mccdn.io\/vitals\/managing-metastatic-prostate-cancer-with-innovative-care\/"},"wordCount":643,"publisher":{"@id":"https:\/\/updates-www.mccdn.io\/vitals\/#organization"},"keywords":["Prostate Cancer"],"articleSection":["Cancer","Profiles &amp; Patient Stories"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/updates-www.mccdn.io\/vitals\/managing-metastatic-prostate-cancer-with-innovative-care\/","url":"https:\/\/updates-www.mccdn.io\/vitals\/managing-metastatic-prostate-cancer-with-innovative-care\/","name":"Managing metastatic prostate cancer with innovative care - MultiCare Vitals","isPartOf":{"@id":"https:\/\/updates-www.mccdn.io\/vitals\/#website"},"datePublished":"2025-09-10T07:00:56+00:00","dateModified":"2025-11-12T23:19:03+00:00","description":"When chemotherapy became less effective against Timothy Taylor\u2019s prostate cancer, his care team turned to a newer treatment called Pluvicto.","breadcrumb":{"@id":"https:\/\/updates-www.mccdn.io\/vitals\/managing-metastatic-prostate-cancer-with-innovative-care\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/updates-www.mccdn.io\/vitals\/managing-metastatic-prostate-cancer-with-innovative-care\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/updates-www.mccdn.io\/vitals\/managing-metastatic-prostate-cancer-with-innovative-care\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/updates-www.mccdn.io\/vitals\/"},{"@type":"ListItem","position":2,"name":"Managing metastatic prostate cancer with innovative care"}]},{"@type":"WebSite","@id":"https:\/\/updates-www.mccdn.io\/vitals\/#website","url":"https:\/\/updates-www.mccdn.io\/vitals\/","name":"MultiCare Vitals","description":"","publisher":{"@id":"https:\/\/updates-www.mccdn.io\/vitals\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/updates-www.mccdn.io\/vitals\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/updates-www.mccdn.io\/vitals\/#organization","name":"MultiCare","url":"https:\/\/updates-www.mccdn.io\/vitals\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/updates-www.mccdn.io\/vitals\/#\/schema\/logo\/image\/","url":"https:\/\/updates-www.mccdn.io\/vitals\/wp-content\/uploads\/sites\/15\/2021\/05\/MultiCare-Color.png","contentUrl":"https:\/\/updates-www.mccdn.io\/vitals\/wp-content\/uploads\/sites\/15\/2021\/05\/MultiCare-Color.png","width":1500,"height":409,"caption":"MultiCare"},"image":{"@id":"https:\/\/updates-www.mccdn.io\/vitals\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/multicarehealthsystem","https:\/\/www.instagram.com\/multicarehealth\/","https:\/\/www.linkedin.com\/company\/multicare-health-system\/mycompany\/","https:\/\/www.youtube.com\/user\/multicarehealth"]},{"@type":"Person","@id":"https:\/\/updates-www.mccdn.io\/vitals\/#\/schema\/person\/7b42102cc747c1354973d979a644ceb6","name":"Helen Vik","url":"https:\/\/updates-www.mccdn.io\/vitals\/author\/helenvik\/"}]}},"gt_translate_keys":[{"key":"link","format":"url"}],"_links":{"self":[{"href":"https:\/\/updates-www.mccdn.io\/vitals\/wp-json\/wp\/v2\/posts\/38181","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/updates-www.mccdn.io\/vitals\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/updates-www.mccdn.io\/vitals\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/updates-www.mccdn.io\/vitals\/wp-json\/wp\/v2\/users\/451"}],"replies":[{"embeddable":true,"href":"https:\/\/updates-www.mccdn.io\/vitals\/wp-json\/wp\/v2\/comments?post=38181"}],"version-history":[{"count":6,"href":"https:\/\/updates-www.mccdn.io\/vitals\/wp-json\/wp\/v2\/posts\/38181\/revisions"}],"predecessor-version":[{"id":38822,"href":"https:\/\/updates-www.mccdn.io\/vitals\/wp-json\/wp\/v2\/posts\/38181\/revisions\/38822"}],"wp:attachment":[{"href":"https:\/\/updates-www.mccdn.io\/vitals\/wp-json\/wp\/v2\/media?parent=38181"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/updates-www.mccdn.io\/vitals\/wp-json\/wp\/v2\/categories?post=38181"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/updates-www.mccdn.io\/vitals\/wp-json\/wp\/v2\/tags?post=38181"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}